[
  {
    "file": "dummy_shortages_irrelevant.ris",
    "expected_label": "irrelevant",
    "total_studies": 3,
    "results": [
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study is a multicenter retrospective study, which is a type of observational study."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines essential medicines, which are pharmaceutical products."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Yes",
          "reasoning": "The study examines medicine stockouts and procurement delays, which are drug supply chain disruptions."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "No",
          "reasoning": "The study does not explicitly examine the impact on drug utilization and access using population-level data. It focuses on stockout events within hospitals."
        },
        "final_decision": "Exclude",
        "decision_reasoning": "Based on the flow logic, this study should be excluded because question 4 was answered with \"No\".",
        "study_index": 0,
        "title": "Impact of Global Supply Chain Disruptions on Essential Medicine Availability in European Hospitals.",
        "abstract": "Background: The COVID-19 pandemic exposed critical vulnerabilities in pharmaceutical supply chains, particularly affecting essential medicine availability in hospital settings across Europe. Objective: To assess the impact of supply chain disruptions on medicine availability and identify factors contributing to stockout events in European hospitals during 2020-2022., Methods: A multicenter retrospective study was conducted across 45 hospitals in 12 European countries. Data on medicine stockouts, procurement delays, and alternative sourcing strategies were collected from hospital pharmacy databases. Statistical analysis included descriptive statistics and regression modeling to identify predictors of stockout events., Results: A total of 2,847 stockout events were documented across participating hospitals, affecting 892 unique medicines. Critical care medications showed the highest vulnerability with 34% experiencing stockouts lasting more than 7 days. Hospitals with diversified supplier networks showed 28% fewer stockout events compared to those relying on single suppliers. The implementation of strategic reserves reduced stockout duration by an average of 3.2 days., Conclusions: Supply chain diversification and strategic stockpiling significantly improve medicine availability during crisis periods. European hospitals should strengthen procurement resilience through multi-supplier strategies and enhanced inventory management systems."
      },
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study implemented AI-driven predictive models in community pharmacies over 18 months and tracked outcomes, which aligns with an observational study design."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines prescription data and medications, including chronic disease medications like diabetes and cardiovascular drugs."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Maybe/Unclear",
          "reasoning": "The study mentions stockouts, which could be related to supply chain disruptions, but it's not explicitly stated."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "No",
          "reasoning": "The study mentions prescription fill rates, but it does not explicitly examine the impact of drug supply chain disruptions on drug utilization and access using population-level data."
        },
        "final_decision": "Exclude",
        "decision_reasoning": "Based on the flow logic, this study should be excluded because it does not examine the impact on drug utilization and access.",
        "study_index": 1,
        "title": "Artificial Intelligence-Driven Predictive Models for Pharmaceutical Inventory Management in Community Pharmacies.",
        "abstract": "Introduction: Traditional inventory management in community pharmacies relies on historical consumption patterns, often resulting in overstocking or stockouts. This study evaluates the effectiveness of machine learning algorithms in optimizing pharmaceutical inventory levels., Methodology: We implemented AI-driven predictive models in 127 community pharmacies across three metropolitan areas over 18 months. The system incorporated real-time prescription data, seasonal variations, and local health trends to forecast demand. Primary outcomes included inventory turnover rates, stockout frequency, and expired medication waste., Findings: Pharmacies using AI-driven inventory management showed a 42% reduction in stockout events and 31% decrease in expired medication waste. Inventory turnover improved by 25%, while maintaining 98.7% prescription fill rates. The system demonstrated particular effectiveness for chronic disease medications, with diabetes and cardiovascular drugs showing the most significant improvements in availability., Discussion: AI-powered inventory management represents a paradigm shift in pharmaceutical logistics. The integration of predictive analytics with traditional pharmacy operations enables proactive rather than reactive inventory decisions. Implementation challenges included staff training and initial system calibration, but benefits emerged within 6 months of deployment., Conclusion: Machine learning algorithms significantly enhance pharmaceutical inventory optimization in community pharmacy settings, improving patient access while reducing waste and operational costs."
      },
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study design includes policy analysis combined with stakeholder interviews and document analysis, which aligns with observational study designs."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines oncology medications, which are pharmaceutical products."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Yes",
          "reasoning": "The study examines shortages of oncology medications, which constitutes a drug supply chain disruption."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "Maybe/Unclear",
          "reasoning": "The study mentions maintaining patient access and survival analysis, but it's unclear if population-level drug utilization data was used. It is unclear if the study examines the impact of drug supply chain disruptions on drug utilization and access using population-level drug utilization data including wholesaler purchasing data, dispensing data, claims data, or drug administration data."
        },
        "final_decision": "Include",
        "decision_reasoning": "Based on the flow logic, this study should be included because the responses to questions 1, 2, and 3 are 'Yes' and the response to question 4 is 'Maybe/Unclear'.",
        "study_index": 2,
        "title": "Regulatory Framework for Emergency Drug Importation: Lessons from the Oncology Medicine Crisis in Australia.",
        "abstract": "Context: Between 2021 and 2022, Australia experienced severe shortages of critical oncology medications, prompting emergency regulatory measures to facilitate drug importation from overseas suppliers. This crisis highlighted gaps in existing pharmaceutical supply chain regulations., Objective: To evaluate the effectiveness of emergency drug importation procedures and propose improvements to regulatory frameworks for managing future medicine shortages., Design: Policy analysis combined with stakeholder interviews from regulatory agencies, hospitals, and pharmaceutical companies. Document analysis of emergency approvals and importation records was conducted., Participants: Interviews were conducted with 67 stakeholders including hospital pharmacists, oncologists, regulatory officials, and pharmaceutical industry representatives., Main Outcomes: Emergency importation procedures enabled access to 23 critical oncology medications during the crisis period. However, the process revealed significant bureaucratic delays, with average approval times of 14 days for emergency applications. Quality assurance protocols for imported medications required standardization, and communication between regulatory bodies and healthcare providers needed improvement., Results: Emergency importation programs successfully maintained patient access to essential cancer treatments during the crisis. Survival analysis showed no significant differences in patient outcomes between standard and imported medications. However, the ad-hoc nature of emergency procedures created uncertainty for healthcare providers and patients., Conclusions: Proactive regulatory frameworks for emergency drug importation can effectively mitigate medicine shortage impacts. Australia should establish pre-approved pathways for critical medication importation and strengthen international regulatory harmonization to prevent future crises."
      }
    ]
  },
  {
    "file": "dummy_shortages_irrelevant.ris",
    "expected_label": "relevant",
    "total_studies": 3,
    "results": [
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study is a multicenter retrospective study, which is a type of observational study."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines essential medicines, which are pharmaceutical products."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Yes",
          "reasoning": "The study examines medicine stockouts and procurement delays, which are drug supply chain disruptions."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "No",
          "reasoning": "The study examines stockout events and duration, but does not explicitly examine the impact on drug utilization and access using population-level data."
        },
        "final_decision": "Exclude",
        "decision_reasoning": "Based on the flow logic, this study should be excluded because it does not examine the impact on drug utilization and access.",
        "study_index": 0,
        "title": "Impact of Global Supply Chain Disruptions on Essential Medicine Availability in European Hospitals.",
        "abstract": "Background: The COVID-19 pandemic exposed critical vulnerabilities in pharmaceutical supply chains, particularly affecting essential medicine availability in hospital settings across Europe. Objective: To assess the impact of supply chain disruptions on medicine availability and identify factors contributing to stockout events in European hospitals during 2020-2022., Methods: A multicenter retrospective study was conducted across 45 hospitals in 12 European countries. Data on medicine stockouts, procurement delays, and alternative sourcing strategies were collected from hospital pharmacy databases. Statistical analysis included descriptive statistics and regression modeling to identify predictors of stockout events., Results: A total of 2,847 stockout events were documented across participating hospitals, affecting 892 unique medicines. Critical care medications showed the highest vulnerability with 34% experiencing stockouts lasting more than 7 days. Hospitals with diversified supplier networks showed 28% fewer stockout events compared to those relying on single suppliers. The implementation of strategic reserves reduced stockout duration by an average of 3.2 days., Conclusions: Supply chain diversification and strategic stockpiling significantly improve medicine availability during crisis periods. European hospitals should strengthen procurement resilience through multi-supplier strategies and enhanced inventory management systems."
      },
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study implemented AI-driven predictive models in community pharmacies over 18 months and tracked outcomes, suggesting an observational study design."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines pharmaceutical inventory levels and prescription fill rates, indicating it examines pharmaceutical products."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Maybe/Unclear",
          "reasoning": "The study mentions stockout events, which could be related to supply chain disruptions, but it's not explicitly stated."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "No",
          "reasoning": "While the study mentions prescription fill rates, it does not explicitly examine the impact of drug supply chain disruptions on drug utilization and access using population-level data."
        },
        "final_decision": "Exclude",
        "decision_reasoning": "Based on the flow logic, this study should be excluded because question 4 was answered with 'No'.",
        "study_index": 1,
        "title": "Artificial Intelligence-Driven Predictive Models for Pharmaceutical Inventory Management in Community Pharmacies.",
        "abstract": "Introduction: Traditional inventory management in community pharmacies relies on historical consumption patterns, often resulting in overstocking or stockouts. This study evaluates the effectiveness of machine learning algorithms in optimizing pharmaceutical inventory levels., Methodology: We implemented AI-driven predictive models in 127 community pharmacies across three metropolitan areas over 18 months. The system incorporated real-time prescription data, seasonal variations, and local health trends to forecast demand. Primary outcomes included inventory turnover rates, stockout frequency, and expired medication waste., Findings: Pharmacies using AI-driven inventory management showed a 42% reduction in stockout events and 31% decrease in expired medication waste. Inventory turnover improved by 25%, while maintaining 98.7% prescription fill rates. The system demonstrated particular effectiveness for chronic disease medications, with diabetes and cardiovascular drugs showing the most significant improvements in availability., Discussion: AI-powered inventory management represents a paradigm shift in pharmaceutical logistics. The integration of predictive analytics with traditional pharmacy operations enables proactive rather than reactive inventory decisions. Implementation challenges included staff training and initial system calibration, but benefits emerged within 6 months of deployment., Conclusion: Machine learning algorithms significantly enhance pharmaceutical inventory optimization in community pharmacy settings, improving patient access while reducing waste and operational costs."
      },
      {
        "question_1_response": {
          "unique_question_id": 1,
          "question_formulation": "Is this an observational study?",
          "response": "Yes",
          "reasoning": "The study design includes policy analysis combined with stakeholder interviews and document analysis, which aligns with observational study designs."
        },
        "question_2_response": {
          "unique_question_id": 2,
          "question_formulation": "Does this study examine pharmaceutical products?",
          "response": "Yes",
          "reasoning": "The study examines oncology medications, which are pharmaceutical products."
        },
        "question_3_response": {
          "unique_question_id": 3,
          "question_formulation": "Does this study examine drug supply chain disruptions?",
          "response": "Yes",
          "reasoning": "The study examines shortages of oncology medications, which are drug supply chain disruptions."
        },
        "question_4_response": {
          "unique_question_id": 4,
          "question_formulation": "Does this study examine the impact on drug utilization and access?",
          "response": "Maybe/Unclear",
          "reasoning": "The study mentions maintaining patient access and survival analysis, but it is unclear if population-level drug utilization data was used."
        },
        "final_decision": "Include",
        "decision_reasoning": "Based on the flow logic, this study should be included because questions 1, 2, and 3 are 'Yes' and question 4 is 'Maybe/Unclear'.",
        "study_index": 2,
        "title": "Regulatory Framework for Emergency Drug Importation: Lessons from the Oncology Medicine Crisis in Australia.",
        "abstract": "Context: Between 2021 and 2022, Australia experienced severe shortages of critical oncology medications, prompting emergency regulatory measures to facilitate drug importation from overseas suppliers. This crisis highlighted gaps in existing pharmaceutical supply chain regulations., Objective: To evaluate the effectiveness of emergency drug importation procedures and propose improvements to regulatory frameworks for managing future medicine shortages., Design: Policy analysis combined with stakeholder interviews from regulatory agencies, hospitals, and pharmaceutical companies. Document analysis of emergency approvals and importation records was conducted., Participants: Interviews were conducted with 67 stakeholders including hospital pharmacists, oncologists, regulatory officials, and pharmaceutical industry representatives., Main Outcomes: Emergency importation procedures enabled access to 23 critical oncology medications during the crisis period. However, the process revealed significant bureaucratic delays, with average approval times of 14 days for emergency applications. Quality assurance protocols for imported medications required standardization, and communication between regulatory bodies and healthcare providers needed improvement., Results: Emergency importation programs successfully maintained patient access to essential cancer treatments during the crisis. Survival analysis showed no significant differences in patient outcomes between standard and imported medications. However, the ad-hoc nature of emergency procedures created uncertainty for healthcare providers and patients., Conclusions: Proactive regulatory frameworks for emergency drug importation can effectively mitigate medicine shortage impacts. Australia should establish pre-approved pathways for critical medication importation and strengthen international regulatory harmonization to prevent future crises."
      }
    ]
  }
]